NCT06039787

Brief Summary

The overarching goal of the current study is to investigate the effect of one acute bout of exercise on the brain insulin responsiveness in a cross-over study design. To this end, investigators will compare the effect of two single endurance exercise sessions with different intensities, namely moderate intensity continuous training (MICT) and high-intensity-interval-training (HIIT), which will be performed in a randomized order. This will be compared to a waiting control condition.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
7mo left

Started Oct 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress81%
Oct 2023Dec 2026

First Submitted

Initial submission to the registry

September 6, 2023

Completed
9 days until next milestone

First Posted

Study publicly available on registry

September 15, 2023

Completed
1 month until next milestone

Study Start

First participant enrolled

October 20, 2023

Completed
3.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

November 8, 2023

Status Verified

September 1, 2023

Enrollment Period

3.2 years

First QC Date

September 6, 2023

Last Update Submit

November 7, 2023

Conditions

Keywords

Exercisefunctional magnetic resonance imagingIntranasal insulin

Outcome Measures

Primary Outcomes (1)

  • Cerebral response after intranasal insulin administration

    The resting-state cerebral response from before to after intranasal insulin administration after a single bout of HIIT or MICT exercise compared to a control condition without exercise (i.e., waiting control)

    1 hour after exercise or waiting control

Secondary Outcomes (6)

  • Task based brain activation after high-intensity-interval-training (HITT) or moderate intensity continuous training (MICT) compared to control condition

    1 hour after exercise or waiting control

  • Subjective feeling of hunger and food craving

    baseline, 1 hour after breakfast, 1 hour, 2 hour, 3 hours after exercise or waiting control

  • Changes in Blood-brain barrier integrity

    1 hour after exercise or waiting control

  • Performance during cognitive tasks

    1 hour after exercise or waiting control

  • Changes in exerkines from plasma samples

    baseline, 1 hour after breakfast, 1 hour, 2 hour, 3 hours after exercise or waiting control

  • +1 more secondary outcomes

Study Arms (3)

moderate intensity continuous training

EXPERIMENTAL
Behavioral: single bout of moderate intensity continuous training (MICT)

High-intensity interval training

EXPERIMENTAL
Behavioral: single bout of High Intensity Interval Training (HIIT)

Waiting condition

PLACEBO COMPARATOR
Behavioral: waiting control

Interventions

the MICT consists of 60 min continuous cycling

moderate intensity continuous training

HIIT consists of 10-min warm-up at the power output corresponding to 50% peak power output (PPO), 4 x 4-min intervals at a power output corresponding to 75% PPO with a 4-min active resting period at 30% PPO to recover

High-intensity interval training
waiting controlBEHAVIORAL

sitting in a waiting room for 60 min

Waiting condition

Eligibility Criteria

Age20 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • BMI between ≥ 19.5 to 39 kg/m2-
  • Less than 150 min/week for moderate-intensity physical activity
  • Less than 75 min/week for Vigorous- intensity exercise (WHO recommendations for regular physical activity of adults)
  • Written consent to participate in the study
  • Written consent to be informed about incidental findings

You may not qualify if:

  • Type 2 diabetes, cardiovascular diseases such as chronic heart failure, myocardial infarction, status post stroke
  • Limitations to participate in ergometer-based exercise (balance and coordination disorders, orthopedic problems, …)
  • Insufficient knowledge of the German language
  • Persons who cannot legally give consent
  • Pregnancy or lactation
  • History of severe mental or somatic disorders including neurological diseases (incl. epileptic seizures and migraines)
  • Taking psychotropic drugs
  • Taking medications that influence glucose metabolism
  • Regular use of analgesic drugs
  • Taking anticoagulant agents
  • Previous bariatric surgery
  • Acute infection within the last 4 weeks
  • Hemoglobin values less than 12g/dl for women, less than 14 g/dl for men
  • Other diseases that in the opinion of the investigator may jeopardize the success of the study or indicate a risk to the volunteer
  • Current participation in a lifestyle intervention study or a pharmaceutical study
  • +4 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Clinic Tübingen, Department of Internal Medicine IV

Tübingen, 72076, Germany

RECRUITING

MeSH Terms

Conditions

Insulin ResistanceObesityMotor Activity

Condition Hierarchy (Ancestors)

HyperinsulinismGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesOverweightOvernutritionNutrition DisordersBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsBehavior

Study Officials

  • Andreas L. Birkenfeld, MD

    Institute for Diabetes research and Metabolic Diseases at the University of Tubingen

    STUDY DIRECTOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Model Details: In a cross-over design, we will compare cerebral response from before to after intranasal insulin administration after a single bout of HIIT or MICT compared to a control condition without exercise.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 6, 2023

First Posted

September 15, 2023

Study Start

October 20, 2023

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

November 8, 2023

Record last verified: 2023-09

Locations